P-tau217: Alzheimer Biomarker Explained
P-tau217 is a biomarker measured in blood or cerebrospinal fluid used for the early diagnosis of Alzheimer's disease, offering high diagnostic accuracy.
Things worth knowing about "P-tau217"
P-tau217 is a biomarker measured in blood or cerebrospinal fluid used for the early diagnosis of Alzheimer's disease, offering high diagnostic accuracy.
What is P-tau217?
P-tau217 (phosphorylated tau protein at threonine 217) is a biological marker (biomarker) that can be measured in the blood or in the cerebrospinal fluid (CSF). It belongs to the family of tau proteins, which play a key role in maintaining the stability of nerve cells in the brain. In Alzheimer's disease, the tau protein becomes abnormally phosphorylated (chemically modified) at specific sites, leading to its malfunction and the formation of so-called neurofibrillary tangles. P-tau217 is considered one of the most specific and earliest measurable changes in the course of the disease.
Biological Background
Tau proteins are normal components of the nervous system and help stabilize structures called microtubules – thread-like structures within nerve cells that are essential for cellular transport. In Alzheimer's disease, excessive phosphorylation of tau causes it to detach from the microtubules and aggregate into toxic tangles. Phosphorylation at the threonine 217 site is particularly characteristic of the Alzheimer's process and distinguishes it from changes seen in other forms of dementia.
Clinical Significance as a Biomarker
P-tau217 is used in research and increasingly in clinical practice as a diagnostic biomarker for Alzheimer's disease. Studies have shown that P-tau217 levels rise many years before clinical symptoms appear – that is, during the so-called preclinical phase of Alzheimer's disease. This makes it particularly valuable for early detection.
- Blood test: Modern immunoassay methods allow the measurement of P-tau217 in blood plasma, enabling minimally invasive diagnostics.
- CSF analysis: Measurement in cerebrospinal fluid via lumbar puncture is highly precise and an established method in dementia diagnostics.
- Differential diagnosis: P-tau217 helps distinguish Alzheimer's disease from other forms of dementia, such as Lewy body dementia or frontotemporal dementia.
Diagnosis and Measurement
P-tau217 is measured using highly sensitive immunoassay technologies, such as Simoa (Single Molecule Array) or electrochemiluminescence-based assays. In clinical studies, P-tau217 has demonstrated very high diagnostic accuracy (AUC values of up to 0.96) in distinguishing Alzheimer's patients from healthy controls. Elevated P-tau217 levels correlate closely with the presence of amyloid plaques in the brain, another hallmark of Alzheimer's disease.
Use in Research and Clinical Practice
P-tau217 is not only a diagnostic marker but is also used as a monitoring parameter in clinical trials to track the effectiveness of new Alzheimer's therapies. With the approval of anti-amyloid antibody therapies (e.g., lecanemab, donanemab), precise biomarker diagnostics has gained considerable importance, as these therapies are most effective when administered in early stages of the disease. In the future, a simple blood test for P-tau217 could become part of the routine diagnostic workup when Alzheimer's disease is suspected.
Comparison with Other Tau Biomarkers
In addition to P-tau217, other tau biomarkers include P-tau181 and P-tau231. However, P-tau217 is considered particularly specific for Alzheimer's pathology and shows changes earlier and more pronounced than the other variants. The choice of the appropriate biomarker depends on the clinical question and the available measurement technology.
References
- Hansson O. et al. - Plasma phospho-tau217 in Alzheimer's disease: a prospective study. Nature Medicine, 2021.
- Alzheimer's Association - 2024 Alzheimer's Disease Facts and Figures. Alzheimer's & Dementia, 2024. Available at: www.alz.org
- Lantero-Rodriguez J. et al. - Plasma p-tau217 accurately predicts amyloid and tau pathology. Brain, 2021.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.